ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Human testing on beta thalassemia patients: CRISPR readied for … – Genetic Literacy Project

Continue reading

2018-03-13 Michael Zand NEWS

Engineers create most efficient red light-activated optogenetic switch for mammalian cells – Phys.Org

Phys.OrgEngineers create most efficient red light-activated optogenetic switch for mammalian cellsPhys.OrgThe team, led by bioengineers at the University of California San Diego, recently detailed their findings online in ACS Synthetic Biology. &quot… Continue reading

2018-03-13 Michael Zand NEWS

Cell and Gene Therapy Catapult to Support UK Network of Advanced Therapies Treatment Centres – PharmiWeb.com (press release)

Cell and Gene Therapy Catapult to Support UK Network of Advanced Therapies Treatment CentresPharmiWeb.com (press release)London, UK, 12 March 2018 – The Cell and Gene Therapy (CGT) Catapult will support three UK sites awarded funding to form a network … Continue reading

2018-03-13 Michael Zand NEWS

Cell and Gene Therapy Catapult to Support UK Network of Advanced Therapies Treatment Centres – PharmiWeb.com (press release)

Cell and Gene Therapy Catapult to Support UK Network of Advanced Therapies Treatment CentresPharmiWeb.com (press release)London, UK, 12 March 2018 – The Cell and Gene Therapy (CGT) Catapult will support three UK sites awarded funding to form a network … Continue reading

2018-03-13 Michael Zand NEWS

The next generation of CRISPR-Cas9 begins – The Student

The StudentThe next generation of CRISPR-Cas9 beginsThe StudentBeing only announced five years ago, CRISPR-Cas9 still feels like a revolutionary new technique – but the next generation of CRISPR-Cas9 technology has already been created. A team of scien… Continue reading

2018-03-13 Michael Zand NEWS

Hitachi Chemical licenses stem cell tech from Israel’s Accellta – גלובס


Genetic Literacy Project

Human testing on beta thalassemia patients: CRISPR readied for …
Genetic Literacy Project
esearchers demonstrated how a gene editing technique, known as Crispr-Cas9, could be used to edit living human cells, raising the possibility that a person’s DNA could be altered much as text is changed by a word-processor. Now, two biotech companies …
The next generation of CRISPR-Cas9 begins | The StudentThe Student
Potential Sickle Cell Disease Treatment Seen in Use of Gene …Sickle Cell Anemia News
The future is now: Editing DNA to treat diseaseKSL.com
PLoS Blogs (blog) –Now. Powered by Northrop Grumman. (blog)
all 8 news articles »
Continue reading

2018-03-13 Michael Zand NEWS

CRISPR helps find new genetic suspects behind ALS/FTD – Drug Target Review

Drug Target ReviewCRISPR helps find new genetic suspects behind ALS/FTDDrug Target ReviewNIH-funded researchers at Stanford University used the gene editing tool CRISPR-Cas9 to rapidly identify genes in the human genome that might modify the severity o… Continue reading

2018-03-13 Michael Zand NEWS

CRISPR Screen Pulls Down Fresh Targets for C9ORF72 ALS – ALS Research Forum

ALS Research ForumCRISPR Screen Pulls Down Fresh Targets for C9ORF72 ALSALS Research ForumIn a March 5 study in Nature Genetics, researchers led by Aaron Gitler and Michael Bassik at Stanford University deployed CRISPR gene editing to screen for modifi… Continue reading

2018-03-13 Michael Zand NEWS
  • 1
  • …
  • 408
  • 409
  • 410
  • 411
  • 412
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

גלובס

Hitachi Chemical licenses stem cell tech from Israel’s Accellta
גלובס
Hitachi Chemical announced its entry into the contracted cell manufacturing market for regenerative medicine in March 2016. In May 2017, Hitachi Chemical completed its acquisition of the US-based company now named Hitachi Chemical Advanced Therapeutics …